What if the reason cancer wins isn't the tumor itself, but the silence it forces on your immune system?
Aaron Edwards grew up in Henderson, Kentucky, left home at sixteen for a bold academic experiment, and spent a decade in biotech working on some of the most cutting-edge gene therapies in the world before asking himself a hard question: why does promising science so rarely reach patients?
That question led him to Harvard, and then to KiraGen Bio, where he and his team are building what he calls "noise-cancelling headphones for cancer therapy." Using gene editing and AI, KiraGen is engineering immune cells that can finally hear through the suppressive environment solid tumors create, and fight back.
In this episode, Aaron and Rosa talk about the journey from a small Kentucky town to the frontier of CAR-T cell therapy, what glioblastoma patients and their families need to know right now, and why the future of cancer treatment should show up in your community clinic, not just at elite academic centers.
In this episode:
- Why CAR-T therapy transforms blood cancers but has largely failed solid tumors until now
- The "noise-cancelling" science behind KiraGen's approach to glioblastoma
- Aaron's concept of "Ms. Frizzles," the teachers and mentors who invest in potential before the outcome is certain
- What an off-the-shelf cell therapy library could mean for everyday cancer patients
- Why $250 million dedicated to pediatric brain tumors could accelerate progress by years
Connect with Aaron: Website: kiragenbio.com LinkedIn X